Cargando…
Striatal Dopamine D(2)-Muscarinic Acetylcholine M(1) Receptor–Receptor Interaction in a Model of Movement Disorders
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by motor control deficits, which is associated with the loss of striatal dopaminergic neurons from the substantia nigra. In parallel to dopaminergic denervation, there is an increase of acetylcholine within the striatum, resultin...
Autores principales: | Crans, René A. J., Wouters, Elise, Valle-León, Marta, Taura, Jaume, Massari, Caio M., Fernández-Dueñas, Víctor, Stove, Christophe P., Ciruela, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083216/ https://www.ncbi.nlm.nih.gov/pubmed/32231561 http://dx.doi.org/10.3389/fphar.2020.00194 |
Ejemplares similares
-
Corrigendum: Striatal dopamine D2-muscarinic acetylcholine M1 receptor-receptor interaction in a model of movement disorders
por: Crans, René A. J., et al.
Publicado: (2022) -
Dopaminergic-cholinergic imbalance in movement disorders: a role for the novel striatal dopamine D(2)- muscarinic acetylcholine M(1) receptor heteromer
por: Crans, René A. J., et al.
Publicado: (2020) -
The muscarinic M(4) acetylcholine receptor exacerbates symptoms of movement disorders
por: Chambers, Nicole E., et al.
Publicado: (2023) -
The mGlu(5) Receptor Protomer-Mediated Dopamine D(2) Receptor Trans-Inhibition Is Dependent on the Adenosine A(2A) Receptor Protomer: Implications for Parkinson’s Disease
por: Romero-Fernandez, Wilber, et al.
Publicado: (2022) -
Allosteric Modulation of Muscarinic Acetylcholine Receptors
por: Gregory, Karen J, et al.
Publicado: (2007)